Citadel Advisors’s Whitehawk Therapeutics, Inc. Common Stock WHWK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$53.4K Sell
28,538
-68,774
-71% -$129K ﹤0.01% 5441
2025
Q1
$173K Buy
97,312
+35,277
+57% +$62.8K ﹤0.01% 4930
2024
Q4
$196K Buy
62,035
+54,591
+733% +$172K ﹤0.01% 4905
2024
Q3
$15.3K Sell
7,444
-485,692
-98% -$1M ﹤0.01% 5389
2024
Q2
$720K Sell
493,136
-24,440
-5% -$35.7K ﹤0.01% 3408
2024
Q1
$1.21M Buy
517,576
+109,854
+27% +$257K ﹤0.01% 2997
2023
Q4
$824K Buy
407,722
+171,456
+73% +$346K ﹤0.01% 3229
2023
Q3
$1.14M Sell
236,266
-22,627
-9% -$110K ﹤0.01% 2914
2023
Q2
$1.77M Sell
258,893
-35,900
-12% -$246K ﹤0.01% 2524
2023
Q1
$2.13M Sell
294,793
-2,201
-0.7% -$15.9K ﹤0.01% 2478
2022
Q4
$3.81M Buy
296,994
+36,974
+14% +$474K ﹤0.01% 2023
2022
Q3
$3.67M Buy
260,020
+26,765
+11% +$378K ﹤0.01% 2142
2022
Q2
$2.87M Sell
233,255
-1,256
-0.5% -$15.5K ﹤0.01% 2392
2022
Q1
$3.98M Buy
234,511
+3,982
+2% +$67.6K ﹤0.01% 2285
2021
Q4
$5.57M Buy
230,529
+131,336
+132% +$3.17M ﹤0.01% 2016
2021
Q3
$2.91M Buy
99,193
+2,249
+2% +$66.1K ﹤0.01% 2589
2021
Q2
$2.46M Buy
96,944
+88,759
+1,084% +$2.25M ﹤0.01% 2980
2021
Q1
$158K Buy
8,185
+2,711
+50% +$52.3K ﹤0.01% 5570
2020
Q4
$80K Sell
5,474
-131,262
-96% -$1.92M ﹤0.01% 4748
2020
Q3
$3.08M Buy
+136,736
New +$3.08M ﹤0.01% 1901
2020
Q2
Sell
-1,069
Closed -$9K 5409
2020
Q1
$9K Buy
+1,069
New +$9K ﹤0.01% 4750
2019
Q4
Sell
-1,422
Closed -$14K 5217
2019
Q3
$14K Buy
+1,422
New +$14K ﹤0.01% 4559